)
)
CollPlant Biotechnologies Investor Relations Material
Latest events
Q2 2024
CollPlant Biotechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from CollPlant Biotechnologies Ltd
Access all reports
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company focused on developing and commercializing products for tissue regeneration and organ manufacturing. The company utilizes its proprietary plant-based recombinant human collagen (rhCollagen) technology to create products that address unmet medical needs in various sectors, including wound care, orthopedics, and 3D bioprinting of tissues and organs. Key offerings include bioinks for 3D printing, wound care products, and orthobiologics. The company collaborates with industry partners to advance its innovative solutions and expand its market presence. The company is headquartered in Rehovot, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
)
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
)
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
CLGN
Country
🇺🇸 United States